Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R8JR
|
||||
| Former ID |
DNC010410
|
||||
| Drug Name |
Propan-2-one O-4-butoxyphenylcarbamoyl oxime
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula |
C14H20N2O3
|
||||
| Canonical SMILES |
CCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C
|
||||
| InChI |
1S/C14H20N2O3/c1-4-5-10-18-13-8-6-12(7-9-13)15-14(17)19-16-11(2)3/h6-9H,4-5,10H2,1-3H3,(H,15,17)
|
||||
| InChIKey |
DFYKIRMDPFHHCI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.